Skip to main content

ZyVersa Therapeutics

Weston, United States

ZyVersa is committed to improving health outcomes and quality of life for patients with inflammatory and renal diseases.

$2.0M raised
Mar 2025
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ZyVersa Therapeutics

How much funding has ZyVersa Therapeutics raised?
ZyVersa Therapeutics has raised $2.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2025.
Who are ZyVersa Therapeutics's investors?
ZyVersa Therapeutics's investors include Michael J. Fox Foundation.
Where is ZyVersa Therapeutics headquartered?
ZyVersa Therapeutics is headquartered in Weston, United States.
What does ZyVersa Therapeutics do?
ZyVersa is committed to improving health outcomes and quality of life for patients with inflammatory and renal diseases.
What stage is ZyVersa Therapeutics at?
ZyVersa Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"ZyVersa Therapeutics — Funding & Investors." VCBacked, March 6, 2025, https://www.vcbacked.co/company/zyversa-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2025). ZyVersa Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/zyversa-therapeutics
Wikipedia (cite web)
{{cite web |title=ZyVersa Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/zyversa-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .